BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou Y, Chen D, Xue G, Yu S, Yuan C, Huang M, Jiang L. Improved therapeutic efficacy of quercetin-loaded polymeric nanoparticles on triple-negative breast cancer by inhibiting uPA. RSC Adv 2020;10:34517-26. [DOI: 10.1039/d0ra04231e] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Chavda VP, Nalla LV, Balar P, Bezbaruah R, Apostolopoulos V, Singla RK, Khadela A, Vora L, Uversky VN. Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer. Cancers 2023;15:1023. [DOI: 10.3390/cancers15041023] [Reference Citation Analysis]
2 Zhou Y, Yu S, Chen D, Li H, Xu P, Yuan C, Jiang L, Huang M. Nafamostat Mesylate in Combination with the Mouse Amino-Terminal Fragment of Urokinase-Human Serum Albumin Improves the Treatment Outcome of Triple-Negative Breast Cancer Therapy. Mol Pharm 2023;20:905-17. [PMID: 36463525 DOI: 10.1021/acs.molpharmaceut.2c00297] [Reference Citation Analysis]
3 Pradhan R, Dey A, Taliyan R, Puri A, Kharavtekar S, Dubey SK. Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer. Pharmaceutics 2023;15. [PMID: 36678877 DOI: 10.3390/pharmaceutics15010246] [Reference Citation Analysis]
4 Ayana G, Ryu J, Choe SW. Ultrasound-Responsive Nanocarriers for Breast Cancer Chemotherapy. Micromachines (Basel) 2022;13:1508. [PMID: 36144131 DOI: 10.3390/mi13091508] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Solanki R, Jodha B, Prabina KE, Aggarwal N, Patel S. Recent advances in phytochemical based nano-drug delivery systems to combat breast cancer: A review. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103832] [Reference Citation Analysis]
6 Abdelkader H, Mustafa WW, Alqahtani AM, Alsharani S, Al Fatease A, Alany RG. Glycation-induced age-related illnesses, antiglycation and drug delivery strategies. J Pharm Pharmacol 2022:rgac051. [PMID: 35972442 DOI: 10.1093/jpp/rgac051] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Chaudhuri A, Kumar DN, Dehari D, Singh S, Kumar P, Bolla PK, Kumar D, Agrawal AK. Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC). Pharmaceuticals 2022;15:542. [DOI: 10.3390/ph15050542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Marchev A, Amirova K, Georgiev M. Genetic Engineering of Cell Cultures for Enhanced Production of Nutraceuticals. Nutraceuticals Production from Plant Cell Factory 2022. [DOI: 10.1007/978-981-16-8858-4_16] [Reference Citation Analysis]
9 Kandekar U, Pujari R. Nanocarrier based precise approaches for anticancer agents in treatment of breast cancer. Hacettepe University Journal of the Faculty of Pharmacy 2021. [DOI: 10.52794/hujpharm.891355] [Reference Citation Analysis]